Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation

Publisher: John Wiley & Sons Inc

E-ISSN: 1349-7006|109|1|182-192

ISSN: 1347-9032

Source: Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 182-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content